SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-23-000053
Filing Date
2023-08-11
Accepted
2023-08-11 16:40:54
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20230630.htm   iXBRL 10-Q 944546
2 EX-31.1 vtvt-20230630xexx311.htm EX-31.1 10109
3 EX-31.2 vtvt-20230630xexx312.htm EX-31.2 10322
4 EX-32.1 vtvt-20230630xexx321.htm EX-32.1 4912
5 EX-32.2 vtvt-20230630xexx322.htm EX-32.2 4879
11 vtvt-20230630_g1.jpg GRAPHIC 138911
  Complete submission text file 0001641489-23-000053.txt   5819316

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20230630.xsd EX-101.SCH 47361
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20230630_cal.xml EX-101.CAL 50798
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20230630_def.xml EX-101.DEF 266609
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20230630_lab.xml EX-101.LAB 526713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20230630_pre.xml EX-101.PRE 361406
62 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20230630_htm.xml XML 657222
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 231164757
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences